Cathie Wood’s Ark Invest boosted its technology, biotechnology, and space exposure last week, led by purchases of more than 51K shares of Meta Platforms (META [https://seekingalpha.com/symbol/META]) worth $38.2M and roughly 360K shares of Rocket Lab (RKLB [https://seekingalpha.com/symbol/RKLB]) worth $25.9M. In biotechnology and genomics, Ark added $8.4M of Scribe Therapeutics (SCTX [https://seekingalpha.com/symbol/SCTX]), $4.5M of Ionis Pharmaceuticals (IONS [https://seekingalpha.com/symbol/IONS]), $4.6M of Veracyte (VCYT [https://seekingalpha.com/symbol/VCYT]), and $4.3M of Beam Therapeutics (BEAM [https://seekingalpha.com/symbol/BEAM]). The funds also added $4.6M of Airbnb (ABNB [https://seekingalpha.
We show the main point publicly. Create a free account to continue reading the full article, save it, discuss it, and connect it with market and OSINT context.